Literature DB >> 23224908

Taurine and atherosclerosis.

Shigeru Murakami1.   

Abstract

Taurine is abundantly present in most mammalian tissues and plays a role in many important physiological functions. Atherosclerosis is the underlying mechanism of cardiovascular disease including myocardial infarctions, strokes and peripheral artery disease and remains a major cause of morbidity and mortality worldwide. Studies conducted in laboratory animal models using both genetic and dietary models of hyperlipidemia have demonstrated that taurine supplementation retards the initiation and progression of atherosclerosis. Epidemiological studies have also suggested that taurine exerts preventive effects on cardiovascular diseases. The present review focuses on the effects of taurine on the pathogenesis of atherosclerosis. In addition, the potential mechanisms by which taurine suppress the development of atherosclerosis will be discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23224908     DOI: 10.1007/s00726-012-1432-6

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  15 in total

Review 1.  Practical strategies for modulating foam cell formation and behavior.

Authors:  Elisabeth Uitz; Babak Bahadori; Mark F McCarty; Mohammed H Moghadasian
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

2.  Neuroprotective Mechanisms of Taurine against Ischemic Stroke.

Authors:  Janet Menzie; Howard Prentice; Jang-Yen Wu
Journal:  Brain Sci       Date:  2013-06-03

3.  1H-NMR-based metabolomic analysis of cerebrospinal fluid from adult bilateral moyamoya disease: comparison with unilateral moyamoya disease and atherosclerotic stenosis.

Authors:  Jin Pyeong Jeon; Taeho Yun; Xing Jin; Won-Sang Cho; Young-Je Son; Jae Seung Bang; Hyun-Seung Kang; Chang Wan Oh; Jeong Eun Kim; Sunghyouk Park
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

4.  Lipid Profile Changes Induced by Chronic Administration of Anabolic Androgenic Steroids and Taurine in Rats.

Authors:  A E Rosca; Camelia Sorina Stancu; Corin Badiu; Bogdan Ovidiu Popescu; Radu Mirica; Constantin Căruntu; Serban Gologan; Suzana Elena Voiculescu; Ana-Maria Zagrean
Journal:  Medicina (Kaunas)       Date:  2019-08-27       Impact factor: 2.430

5.  Diminazene Aceturate Stabilizes Atherosclerotic Plaque and Attenuates Hepatic Steatosis in apoE-Knockout Mice by Influencing Macrophages Polarization and Taurine Biosynthesis.

Authors:  Aneta Stachowicz; Anna Wiśniewska; Katarzyna Kuś; Magdalena Białas; Magdalena Łomnicka; Justyna Totoń-Żurańska; Anna Kiepura; Kamila Stachyra; Maciej Suski; Beata Bujak-Giżycka; Jacek Jawień; Rafał Olszanecki
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

Review 6.  Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation.

Authors:  Yang Bai; Xiaolu Wang; Song Zhao; Chunye Ma; Jiuwei Cui; Yang Zheng
Journal:  Oxid Med Cell Longev       Date:  2015-10-25       Impact factor: 6.543

7.  Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats.

Authors:  A E Roşca; I Stoian; C Badiu; L Gaman; B O Popescu; L Iosif; R Mirica; I C Tivig; C S Stancu; C Căruntu; S E Voiculescu; L Zăgrean
Journal:  Braz J Med Biol Res       Date:  2016-05-31       Impact factor: 2.590

8.  Boosting endogenous production of vasoprotective hydrogen sulfide via supplementation with taurine and N-acetylcysteine: a novel way to promote cardiovascular health.

Authors:  James J DiNicolantonio; James H OKeefe; Mark F McCarty
Journal:  Open Heart       Date:  2017-05-22

Review 9.  Nutrients in Fish and Possible Associations with Cardiovascular Disease Risk Factors in Metabolic Syndrome.

Authors:  Christine Tørris; Milada Cvancarova Småstuen; Marianne Molin
Journal:  Nutrients       Date:  2018-07-23       Impact factor: 5.717

Review 10.  Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure.

Authors:  Mark F McCarty
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.